Review of hospitalized newborns due to indirect hyperbilirubinemia: A retrospective, observational study

Aim: The aim of our study to identify characteristics of patients admitted to our hospital due to indirect hyperbilirubinemia and todetermine risk factors for indirect hyperbilirubinemia.Material and Methods: The study included 130 patients (gestational age≥36 weeks) who admitted to newborn clinic with thediagnosis of indirect hyperbilirubinemia. In all patients, risk factors, peripheral venous serum samples, complete blood count andbiochemical parameters before and after phototherapy were assessed. The phototherapy and exchange transfusion decisions weremade according to total serum bilirubin (TSB) levels proposed by Turkish Neonatology Association.Result: In patients included, mean gestational age was 38.54±0.95 weeks (range: 36-41) while mean birth weight was 3241.53±414.60g (range: 2020-4400). Of the patients, 71 (54.6%) were boys. Time of presentation was 3.56±1.2 days while total bilirubin level was21.31±3.83 mg/dL. No underlying cause was detected in 71 patients while there was dehydration in 30 (23.0%), ABO incompatibilityin 41 (31.5%) and Rh incompatibility in 20 patients (15.3%). Mean phototherapy duration was 69.78±20.36 hours (range: 48-120).Seven patients received intravenous immunoglobulin (IVIG) therapy. Of these, there was Rh incompatibility in 4 patients and ABOincompatibility in 3 patients. Overall, 6 patients underwent exchange transfusion. In 3 patients, exchange transfusion was requireddespite IVIG therapy. The hemoglobin, MCV and total bilirubin levels were 15.89±2.92 g/dL, 105.51±6.59 fL and 21.31±3.83 mg/dLbefore therapy whereas 14.07±2.90 g/dL, 101.41±8.15 fL and 11.33±2.18 mg/dl after therapy, respectively.Conclusion: Based on our results, the most common cause of hyperbilirubinemia is idiopathic jaundice ((most probably physiologicaljaundice or breast milk jaundice) in newborns; followed by ABO incompatibility.

PDF

___

1. Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn. https://www.uptodate.com/contents/pathogenesis-and-etiology-of unconjugated-hyperbilirubinemia-in-the-newborn last update 05.12.2018
2. Soldi A, Tonetto P, Chiale F, et al. Hyperbilirubinemia and management of breastfeeding. J Biol Regul Homeost Agents 2012;26:25-9.
3. Maisels MJ. Neonatal jaundice. Pediatr Rev 2006;27:443-54.
4. Kliegman RM. Nelson pediatrics. In: Ambalavanan N, editor. Jaundice and hyperbilirubinemia in newborn. Philedelphia; 2011. p. 603.
5. Maisels MJ. Neonatal Jaundice. In: Avery G, Fletcher MA, MacDonald MG. eds. Neonatology: Pathophysiology & Management of the Newborn. Fifth edition. Lippincott Williams & Wilkins; 1999. p. 765-820.
6. Ding G, Zhang S, Yao D, et al. An epidemiological survey on neonatal jaundice in china. Chin Med J (Engl) 2001;114:344-7.
7. Aslan Y, Erduran E, Gedik Y, et al. İndirek hiperbilirubinemili yenidoğanlarda Kell, C ve E subgrup uyuşmazlıkları. T Klin J Pediatr 1996;5:93-8.
8. Alp H, Altınkaynak S, Energin VM, ve ark. Yenidoğanda hiperbilirubinemi sorunu: Etyolojik degerlendirme ve tedavi sonuçları. Çocuk Sağlığı ve Hastalıkları Dergisi 1995;38:47-55.
9. Bolat F, Uslu S, Bülbül A, et al. Comparison of ABO and Rh incompatibility in neonatal indirect hyperbilirubinemia. Ş.E.E.A.H Tıp Bülteni 2010;44:156-61.
10. Okan MA. A retrospective evaluation of etiology in neonatal jaundice infants were treated with phototherapy. J Kartal TR 2014;25:215-9.
11. Kahveci M, Çeltik C, Acunaş B. Yenidoğan dönemindeki patolojik sarılıklı olguların değerlendirilmesi. Sted 2004:13:215-9.
12. Yiğit Ö, Sezgin B, Gamze Ö, et al. İndirekt hiperbilirubinemili olguların değerlendirilmesi. Bakırköy Tıp Dergisi 2006;2:41-6.
13. Kılıç İ, Ergin H, Çakaloz İ. The evaluation of indirect hyperbilirubinemia cases in newborn period. Turkiye Klinikleri J of Pediatrics 2005;14:20-5.
14. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-306.
15. Sivasli E. Yenidoğan bebeklerde uzamış sarılık. Gaziantep Tıp Dergisi 2009;15:49-55.
16. Newman TB, Escobar GJ, Gonzales VM, et al. Frequency of neonatal bilirubin testing and hyperbiliru-binemia in a large health maintenance organization. Pediatrics 1999;104:1198-203.
17. Bülbül A OF, Uslu S, İşçi E, ve ark Term bebeklerde hiperbilirubineminin klinik özellikleri ve risk etmenlerinin araştırılması. Türk Pediatri Arşivi 2005;40:204-10.
18. Katar S DC, Özel K, Sucaklı İ. Kan değişimi yapılan yenidoğan bebeklerde hiperbilirubinemi etiyolojisinin değerlendirilmesi. Dicle Tıp Dergisi 2006;33:174-7.